Natural Products for Cancer Prevention and Therapy: Progress, Pitfalls and Promise

Clicks: 442
ID: 34704
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #4 of 41 articles by views in proceedings

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Natural products represent a valuable resource for discovery and development of anticancer drugs. About 80% of drugs approved by the United States Food and Drug Administration during the last three decades for cancer therapy are either natural products per se or are based on, or mimicked natural products. Various extracts, fractions, mixtures and pure compounds from dietary sources, medicinal plants and marine organisms have been found to exhibit potent antiproliferative and cytotoxic activities against numerous cancer cell lines. These agents have also been tested for cancer preventive and therapeutic efficacies using preclinical animal cancer models that resemble human disease. Selected natural products have also entered into clinical studies. The cancer preventive and anticancer attributes of various natural products can be explained by multiple cellular and molecular mechanisms, including scavenging of free radicals, detoxification of carcinogens, DNA repair, alteration of cell cycles, programmed cell death (apoptosis), autophagy, immune surveillance, anti-inflammatory, anti-angiogenic, anti-invasive and antimetastatic activities as well as their ability to modulate a plethora of dysregulated oncogenic signaling pathways. This presentation aims to highlight studies on cancer preventive and therapeutic attributes of various naturally occurring agents and underlying mechanisms of action, with special emphasis on results reported from our laboratory. Current limitations, challenges, and future directions of research for successful cancer drug development based on natural products will also be discussed.
Reference Key
bishayee2017naturalproceedings Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bishayee, Anupam;
Journal proceedings
Year 2017
DOI
DOI not found
URL
https://www.mdpi.com/2504-3900/1/10/982
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.